Novel Treatment Advances and Approaches in the Management of Chronic Cough With Unexplained Cause: Emerging Therapies for Improved
Clinical and Economic Outcomes

A continuing medical education activity sponsored by NAMCP and AAMCN

Novel Treatment Advances and Approaches in the Management of Chronic Cough With Unexplained Cause: Emerging Therapies for Improved Clinical and Economic Outcomes is a two-part webinar series focusing on the latest developments on chronic cough

These are archives of live webinars held between August 20 and August 25, 2020.
If you participated in any of the live webinars, you are not eligible to
claim credit from the archive of that webinar.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all three or in order.

These activities are valid from September 1, 2020 to September 1, 2022


This series is supported by an educational grant from Merck Sharp & Dohme Corp.


 
Audience: This activity is intended for healthcare professionals practicing in managed care environments.

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

Description:
Chronic cough, which is observed in approximately 12% of the US population, is defined as a cough that lasts for more than 8 weeks. Patients with chronic cough are often distressed by the condition, which can lead to depression, anxiety, a decline in quality of life, and changes to their social activities. The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. This educational activity will review the burden of chronic cough, discuss the current recommendations for the management of patients with chronic cough, and evaluate the latest clinical data regarding emerging pharmacotherapies for the treatment of patients with refractory chronic cough.


Novel Treatment Advances and Approaches in the Management of Chronic Cough With Unexplained Causes

  1. Review the clinical and economic burden of chronic cough, particularly in patients who do not find relief from recommended management strategies
  2. Evaluate the current recommendations for the management of patients with chronic cough and the unmet patient needs
  3. Analyze the mechanisms of action as well as the latest clinical data regarding emerging pharmacotherapies to treat patients with refractory chronic cough
  4. Examine the emerging role of P2X3 receptor antagonists in the management of refractory or unexplained chronic cough
       Physician, Nursing and CMCN credits valid to September 1, 2022

What Managed Care Needs to Know About Chronic Cough: Novel Therapies for Improved Outcomes

  1. Review the economic burden of chronic cough, particularly in patients who do not find relief from recommended management strategies
  2. Analyze the mechanisms of action as well as the latest clinical data regarding emerging pharmacotherapies to treat patients with refractory chronic cough
  3. Examine managed care considerations of emerging P2X3 receptor antagonists in the management of refractory or unexplained chronic cough
  4. Discuss the role of managed care professionals within the collaborative care team for effective therapy management for patients with chronic cough
       Physician, Nursing and CMCN credits valid to September 1, 2022